Restrictive Transfusion Thresholds in Hospital Practice

Blood transfusion can be lifesaving, but a low haemoglobin result alone does not always justify red blood cell (RBC) administration. Every unit carries clinical workload, exposure to transfusion reactions and a demand on a finite blood supply. The HM17 discussion of restrictive thresholds placed transfusion decisions within a broader patient blood management approach: assess the person, identify the cause of anaemia and treat the problem rather than reacting automatically to a laboratory number.

For Australian hospitalists, the message remains relevant across metropolitan and regional services. A patient in Melbourne with stable postoperative anaemia, a person transferred between hospitals in regional Queensland and an older inpatient in Perth may all have different risks, symptoms and access to rapid support. The threshold is a useful safety boundary, not a substitute for clinical judgement.

What Restrictive Thresholds Actually Mean

A restrictive strategy generally means considering transfusion at a haemoglobin concentration around 70 g/L for adults who are clinically stable and not actively bleeding. In selected groups, including people undergoing cardiac or orthopaedic surgery or those with pre-existing cardiovascular disease, a threshold near 80 g/L may be appropriate. These figures reflect the broad direction of evidence reviewed around HM17, rather than an instruction to delay care in a deteriorating patient.

The key distinction is between a threshold and a trigger. A result below 70 g/L should prompt assessment, not an automatic order for two units. Look for chest pain, dyspnoea at rest, syncope, persistent tachycardia, hypotension, impaired function or other evidence that anaemia is causing harm. A stable patient with chronic anaemia may tolerate a lower concentration than someone with limited cardiac reserve and new exertional symptoms.

The HM17 conference archive provides the historical setting for the meeting’s education on research, best practice and patient care. Its value for current practice is the decision-making framework: transfusion should have a clear indication, a defined goal and a plan to reassess whether that goal was achieved.

Use One Unit And Reassess

For a non-bleeding adult, a single-unit RBC prescription is usually a safer starting point than routinely ordering two units. One unit commonly increases haemoglobin by approximately 10 g/L in an average adult, although the response varies with body size, ongoing blood loss, fluid balance and the underlying illness. Recheck the patient clinically and repeat the blood count when it will change management.

This approach can prevent avoidable exposure. A patient who feels better after one unit and has reached a reasonable concentration may gain little from another unit. The prescription should state why the unit is being given and what outcome will be reviewed. At the bedside, record symptoms, pulse, blood pressure, oxygen requirement and any signs of transfusion reaction.

A restrictive policy does not mean withholding blood from a patient with shock, major haemorrhage or ongoing loss. In those circumstances, haemoglobin may initially appear deceptively reassuring because the circulating blood has not yet equilibrated. Activate the local major haemorrhage pathway when indicated, control the source and use serial clinical and laboratory assessments rather than waiting for a particular number.

Medication review also matters. Anticoagulants, antiplatelet therapy and renal disease can alter the risk of bleeding or affect recovery from anaemia. The HM17 material on oral anticoagulant guidance is a useful reminder that medication-related bleeding risk needs a separate plan; a transfusion may stabilise oxygen delivery without addressing the cause of blood loss.

Build The Decision Around The Patient

Before ordering RBCs, establish whether the anaemia is acute or chronic and whether the haemoglobin is falling. Review the admission blood count, operative notes, drain output, stool or urine loss, phlebotomy volume and fluid administration. Iron deficiency, inflammation, kidney disease, nutritional deficiency and marrow disorders require targeted treatment, not repeated transfusion as a default.

Symptoms should be interpreted in context. Breathlessness may arise from pneumonia or pulmonary oedema, while tachycardia may reflect infection, pain or dehydration. Conversely, an older person with coronary disease may show reduced mobility or confusion rather than describing classic chest pain. Shared decisions are particularly important when transfusion is unlikely to improve long-term function or when a patient has previously expressed preferences about blood products.

Australian practice is shaped by the National Blood Authority’s patient blood management guidance and the NSQHS Blood Management Standard. Blood components are therapeutic goods regulated within the framework of the Therapeutic Goods Act 1989, while consent, documentation and clinical governance also operate through state and territory requirements. Hospitals should therefore align the bedside policy with their transfusion service, local consent process and escalation arrangements.

The Australian supply model makes stewardship practical rather than theoretical. Australian Red Cross Lifeblood supplies the national system, but stock still has to move to hospitals and may be harder to replace for a regional service than for a large Sydney or Melbourne centre. In Perth, Brisbane and other cities, a restrictive single-unit approach can reduce unnecessary demand while preserving capacity for trauma, obstetrics and major surgery.

Make Anaemia Management Part Of Routine Care

Prevention begins before the haemoglobin reaches a transfusion threshold. Check for iron deficiency when appropriate, manage renal and inflammatory contributors, reduce unnecessary blood sampling and use paediatric or low-volume tubes when clinically suitable. In Australian hospitals, early-morning collection rounds and repeated tests during a long admission can remove a meaningful volume of blood, particularly from small or frail adults.

Perioperative pathways should identify anaemia early enough to treat it before surgery. Oral or intravenous iron may be suitable depending on the cause, urgency and tolerance. Surgeons, anaesthetists, physicians, pharmacists and nurses should agree on how to manage antithrombotic medicines and bleeding risk. A clear plan reduces the chance that a postoperative result will trigger an isolated, poorly considered transfusion decision.

Mobility and function help define whether anaemia is clinically significant. A patient who cannot participate in rehabilitation may need investigation, but the answer may involve pain control, physiotherapy, infection treatment or respiratory support rather than RBCs. HM17’s early mobility stories illustrate why recovery outcomes should remain visible when clinicians assess whether a treatment has helped.

For Australian teams, everyday communication is another safety measure. Include haemoglobin trends, transfusion thresholds, bleeding status and review times in ward-round notes and evening handover. This is especially important when a patient moves from an emergency department to a medical ward, between public and private hospitals or from a tertiary centre to a smaller regional facility.

Turn The Threshold Into A Ward Standard

A practical local protocol can be brief: assess bleeding and haemodynamic stability, identify symptoms attributable to anaemia, consider the relevant threshold, prescribe one unit when appropriate, document the indication and reassess. Exceptions should be explicit for major haemorrhage, acute coronary syndromes, severe hypoxaemia and other specialist situations where evidence or physiology differs.

Education works best when it uses real cases. Review patients who received two units when one may have been sufficient, transfusions given without documented symptoms and cases where iron deficiency or ongoing bleeding was missed. Audit can track units per admission, single-unit compliance, pre-transfusion haemoglobin, reaction rates and documentation of post-transfusion review.

The policy should also recognise local habits and resources. A weekend pathology schedule, delayed access to iron infusion, or long transfer distances in rural Australia may influence timing, but these factors should not become an automatic reason for liberal transfusion. Planning ahead is safer: investigate anaemia during the first assessment, communicate the threshold during handover and escalate early when the patient is unstable.

At the next ward round, select one stable non-bleeding patient with anaemia, document the symptoms, haemoglobin trend and transfusion goal, and decide explicitly whether observation, treatment of the cause or a single RBC unit is the safest option.